An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases

Fitoterapia

Volumn 106, Issue , 2015, Pages 12-21

  Giacoppo, Sabrina ^a   Galuppo, Maria ^a   Montaut, Sabine ^b   Iori, Renato ^c   Rollin, Patrick ^d   Bramanti, Placido ^a   Mazzon, Emanuela ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b LAURENTIAN UNIVERSITY   (Canada)

^c ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^d UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Brassicaceae; Isothiocyanates; Moringaceae; Neurodegenerative diseases; Nrf2 ARE pathway; Oxidative stress

Indexed keywords

3 NITROTYROSINE; AMYLOID BETA PROTEIN[1-40]; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; GLUCOMORINGIN ISOTHIOCYANIC ACID; GLUCORAPHANIN; GLUCOSINOLATE; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; ISOTHIOCYANIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MORINGIN; NEUROMODULIN; NEUROPROTECTIVE AGENT; PLANT EXTRACT; PROTEASOME; PROTEIN BAX; PROTEIN BCL 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SULFORAPHANE; TAU PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; UBIQUITIN; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ISOTHIOCYANIC ACID; PLANT MEDICINAL PRODUCT;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRASSICA; BRASSICACEAE; BROCCOLI; BRUSSELS SPROUT; CAROTID ARTERY OBSTRUCTION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DNA FRAGMENTATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; HUNTINGTON CHOREA; HYDROLYSIS; IN VITRO STUDY; KALE; MEMBRANE DAMAGE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORINGA OLEIFERA; MORINGACEAE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; VEGETABLE; CHEMISTRY; DRUG EFFECTS; NEURODEGENERATIVE DISEASES;

BRASSICA; BRASSICACEAE; MORINGACEAE;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BRASSICA; HUMANS; ISOTHIOCYANATES; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHYTOCHEMICALS;

EID: 84938887005     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2015.08.001     Document Type: Review

References (92)

1. F. Fuentes, X. Paredes-Gonzalez, and A.-N.T. Kong Dietary glucosinolates sulforaphane, phenethyl isothiocyanate, indole-3-carbinol/3,3′-diindolylmethane: antioxidative stress/inflammation, Nrf2, epigenetics/epigenomics and in vivo cancer chemopreventive efficacy Curr. Pharmacol. Rep. 1 2015 179 196
2. N.S. Alrawaiq, and A. Abdullah An evaluation of sulforaphane as a potential agent for disease prevention Res. J. Pharm. Biol. Chem. Sci. 5 2014 1335 1349
3. V. Calabrese, C. Cornelius, A.T. Dinkova-Kostova, I. Iavicoli, R. Di Paola, A. Koverech, and et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity Biochim. Biophys. Acta Mol. Basis Dis. 2012 1822 753 783
4. Y. Zhang, P. Talalay, C.G. Cho, and G.H. Posner A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure Proc. Natl. Acad. Sci. U. S. A. 89 1992 2399 2403
5. I.M.A. Ernst, K. Palani, T. Esatbeyoglu, K. Schwarz, and G. Rimbach Synthesis and Nrf2-inducing activity of the isothiocyanates iberverin, iberin and cheirolin Pharmacol. Res. 70 2013 155 162
6. J.W. Fahey, A.T. Zalcmann, and P. Talalay The chemical diversity and distribution of glucosinolates and isothiocyanates among plants Phytochemistry 56 2001 5 51
7. N. Agerbirk, and C.E. Olsen Glucosinolate structures in evolution Phytochemistry 77 2012 16 45
8. G.R. De Nicola, P. Rollin, E. Mazzon, and R. Iori Novel gram-scale production of enantiopure R-sulforaphane from Tuscan black kale seeds Molecules 19 2014 6975 6986
9. F. Vergara, M. Wenzler, B.G. Hansen, D.J. Kliebenstein, B.A. Halkier, J. Gershenzon, and et al. Determination of the absolute configuration of the glucosinolate methyl sulfoxide group reveals a stereospecific biosynthesis of the side chain Phytochemistry 69 2008 2737 2742
10. A.F. Abdull Razis, R. Iori, and C. Ioannides The natural chemopreventive phytochemical R-sulforaphane is a far more potent inducer of the carcinogen-detoxifying enzyme systems in rat liver and lung than the S-isomer Int. J. Cancer 128 2011 2775 2782
11. F. Elbarbry, and N. Elrody Potential health benefits of sulforaphane: a review of the experimental, clinical and epidemiological evidences and underlying mechanisms J. Med. Plant Res. 5 2011 473 484
12. M. Galuppo, S. Giacoppo, G.R. De Nicola, R. Iori, M. Navarra, G.E. Lombardo, and et al. Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis Fitoterapia 95 2014 160 174
13. S.K. Biswas, A. Chowdhury, J. Das, A. Roy, and S.M. Zahid Hosen Pharmacological potentials of Moringa oleifera Lam.: a review Int. J. Pharm. Sci. Res. 47 2012 305 310
14. K.A. Jellinger Recent advances in our understanding of neurodegeneration J. Neural Transm. 116 2009 1111 1162
15. V. Calabrese, E. Guagliano, M. Sapienza, M. Panebianco, S. Calafato, E. Puleo, and et al. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes Neurochem. Res. 32 2007 757 773
16. K.J. Barnham, C.L. Masters, and A.I. Bush Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discov. 3 2004 205 214
17. A.T. Dinkova-Kostova, and R.V. Kostov Glucosinolates and isothiocyanates in health and disease Trends Mol. Med. 18 2012 337 347
18. B. Holst, and G. Williamson A critical review of the bioavailability of glucosinolates and related compounds Nat. Prod. Rep. 21 2004 425 447
19. C. Fimognari, E. Turrini, L. Ferruzzi, M. Lenzi, and P. Hrelia Natural isothiocyanates: genotoxic potential versus chemoprevention Mutat. Res. 750 2012 107 131
20. A. Tarozzi, C. Angeloni, M. Malaguti, F. Morroni, S. Hrelia, and P. Hrelia Sulforaphane as a potential protective phytochemical against neurodegenerative diseases Oxidative Med. Cell. Longev. 2013 2013 415078
21. S. Boddupalli, J.R. Mein, S. Lakkanna, and D.R. James Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and E Front. Genet. 3 2012 7
22. R. Hu, V. Hebbar, B.R. Kim, C. Chen, B. Winnik, B. Buckley, and et al. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat J. Pharmacol. Exp. Ther. 310 2004 263 271
23. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, and et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc. Natl. Acad. Sci. U. S. A. 99 2002 11908 11913
24. B. Sriramoju, R.K. Kanwar, and J.R. Kanwar Nanoformulated mutant SurR9-C84A: a possible key for Alzheimer's and its associated inflammation Pharm. Res. Mar 14 2015 10.1007/s 11095-015-1664-8
25. C.M. Dobson Protein folding and misfolding Nature 426 2003 884 890
26. K. Mi, and G.V. Johnson The role of tau phosphorylation in the pathogenesis of Alzheimer's disease Curr. Alzheimer Res. 3 2006 449 463
27. R.K. Tannenberg, H.L. Scott, A.E.G. Tannenberg, and P.R. Dodd Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE ε4 Neurochem. Int. 49 2006 631 639
28. C. Behl Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches Prog. Neurobiol. 57 1999 301 323
29. A. Salminen, J. Ojala, A. Kauppinen, K. Kaarniranta, and T. Suuronen Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors Prog. Neurobiol. 87 2009 181 194
30. A.L. Goldberg Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy Biochem. Soc. Trans. 35 2007 12 17
31. H.-M. Park, J.-A. Kim, and M.-K. Kwak Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome Arch. Pharm. Res. 32 2009 109 115
32. N. Gan, Y.-C. Wu, M. Brunet, C. Garrido, F.-L. Chung, C. Dai, and et al. Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27 J. Biol. Chem. 285 2010 35528 35536
33. M.Y. Sherman, and A.L. Goldberg Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases Neuron. 29 2001 15 32
34. H.V. Kim, H.Y. Kim, H.Y. Ehrlich, S.Y. Choi, D.J. Kim, and Y. Kim Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model Amyloid 20 2013 7 12
35. J.K. Kim, E.-C. Shin, C.R. Kim, G.G. Park, S.J. Choi, C.-S. Park, and et al. Effects of Brussels sprouts and their phytochemical components on oxidative stress-induced neuronal damages in PC12 cells and ICR mice J. Med. Food 16 2013 1057 1061
36. R. Ganguly, and D. Guha Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera Indian J. Med. Res. 128 2008 744 751
37. R. Ganguly, K. Ray, and D. Guha Effect of Moringa oleifera in experimental model of Alzheimer's disease: role of antioxidants Ann. Neurosci. 12 2005 36 39
38. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 5646 2003 819 822
39. G.E. Meredith, P.K. Sonsalla, and M.-F. Chesselet Animal models of Parkinson's disease progression Acta Neuropathol. 115 2008 385 398
40. A. Jazwa, A.I. Rojo, N.G. Innamorato, M. Hesse, J. Fernandez-Ruiz, and A. Cuadrado Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism Antioxid. Redox Signal. 14 2011 2347 2360
41. F. Morroni, A. Tarozzi, G. Sita, C. Bolondi, J.M. Zolezzi Moraga, G. Cantelli-Forti, and P. Hrelia Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease Neurotoxicology 36 2013 63 71
42. A. Wellejus, H. Elbrond-Bek, N.M. Kelly, M.S. Weidner, and S.H. Jorgensen 4-Iodophenyl isothiocyanate: a neuroprotective compound Restor. Neurol. Neurosci. 30 2012 21 38
43. S)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease Bioorg. Med. Chem. 21 2013 5532 5547
44. A. Tarozzi, F. Morroni, A. Merlicco, S. Hrelia, C. Angeloni, G. Cantelli-Forti, and et al. Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line J. Neurochem. 111 2009 1161 1171
45. C. Deng, R. Tao, S.Z. Yu, and H. Jin Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation Mol. Med. Rep. 6 2012 215 219
46. C. Deng, R. Tao, S.Z. Yu, and H. Jin Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner Mol. Med. Rep. 5 2012 847 851
47. J.M. Han, Y.J. Lee, S.Y. Lee, E.M. Kim, Y. Moon, H.W. Kim, and et al. Protective effect of sulforaphane against dopaminergic cell death J. Pharmacol. Exp. Ther. 321 2007 249 256
48. J.P.E. Spencer, M. Whiteman, P. Jenner, and B. Halliwell 5-S-cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons J. Neurochem. 81 2002 122 129
49. D. Vauzour, K. Vafeiadou, and J.P.E. Spencer Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols Biochem. Biophys. Res. Commun. 362 2007 340 346
50. J.P.E. Spencer, P. Jenner, S.E. Daniel, A.J. Lees, D.C. Marsden, and B. Halliwell Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species J. Neurochem. 71 1998 2112 2122
51. D. Vauzour, M. Buonfiglio, G. Corona, J. Chirafisi, K. Vafeiadou, C. Angeloni, and et al. Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes Mol. Nutr. Food Res. 54 2010 532 542
52. C.A. Ross, and S.J. Tabrizi Huntington's disease: from molecular pathogenesis to clinical treatment Lancet Neurol. 10 2011 83 98
53. M.-K. Kwak, J.-M. Cho, B. Huang, S. Shin, and T.W. Kensler Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells Free Radic. Biol. Med. 43 2007 809 817
54. Y. Liu, C.L. Hettinger, D. Zhang, K. Rezvani, X. Wang, and H. Wang Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease J. Neurochem. 129 2014 539 547
55. M. Sospedra, and R. Martin Immunology of multiple sclerosis Annu. Rev. Immunol. 23 2005 683 747
56. R. Gold, C. Linington, and H. Lassmann Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research Brain 129 2006 1953 1971
57. B. Li, W. Cui, J. Liu, R. Li, Q. Liu, X.-H. Xie, and et al. Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice Exp. Neurol. 250 2013 239 249
58. N.A. Kelsey, H.M. Wilkins, and D.A. Linseman Nutraceutical antioxidants as novel neuroprotective agents Molecules. 15 2010 7792 7814
59. S)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis Eur. Rev. Med. Pharmacol. Sci. 18 2013 194 204
60. S)-glucoraphanin bioactivated with myrosinase in an experimental model of multiple sclerosis CNS Neurosci. Ther. 19 2013 577 584
61. L.C. Wijesekera, and P.N. Leigh Amyotrophic lateral sclerosis Orphanet J. Rare Dis. 4 2009 3
62. W. Duan, X. Li, J. Shi, Y. Guo, Z. Li, Li C. Mutant, and TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell Neuroscience 169 2010 1621 1629
63. M. Malaguti, C. Angeloni, N. Garatachea, M. Baldini, E. Leoncini, P.S. Collado, and et al. Sulforaphane treatment protects skeletal muscle against damage induced by exhaustive exercise in rats J. Appl. Physiol. 107 2009 1028 1036
64. G. Chang, Y. Guo, Y. Jia, W. Duan, B. Li, J. Yu, and et al. Protective effect of combination of sulforaphane and riluzole on glutamate-mediated excitotoxicity Biol. Pharm. Bull. 33 2010 1477 1483
65. M. Galuppo, S. Giacoppo, R. Iori, G.R. De Nicola, P. Bramanti, and E. Mazzon Administration of 4-(α-l-rhamnosyloxy)-benzyl isothiocyanate delays disease phenotype in SOD1G93A rats: a transgenic model of amyotrophic lateral sclerosis BioMed. Res. Int. 2015 10.1155/2015/259417
66. V.L. Feigin, C.M.M. Lawes, D.A. Bennett, and C.S. Anderson Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century Lancet Neurol. 2 2003 43 53
67. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
68. P.H. Chan Reactive oxygen radicals in signaling and damage in the ischemic brain J. Cereb. Blood Flow Metab. 21 2001 2 14
69. R. Jin, G. Yang, and G. Li Inflammatory mechanisms in ischemic stroke: role of inflammatory cells J. Leukoc. Biol. 87 2010 779 789
70. G. del Zoppo, I. Ginis, J.M. Hallenbeck, C. Iadecola, X. Wang, and G.Z. Feuerstein Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia Brain Pathol. 10 2000 95 112
71. M.A. Moskowitz, E.H. Lo, and C. Iadecola The science of stroke: mechanisms in search of treatments Neuron 67 2010 181 198
72. S)-glucoraphanin purified from Tuscan black kale and bioactivated with myrosinase enzyme protects against cerebral ischemia/reperfusion injury in rats Fitoterapia 99 2014 166 177
73. M.H. Noyan-Ashraf, Z. Sadeghinejad, and B.H.J. Juurlink Dietary approach to decrease aging-related CNS inflammation Nutr. Neurosci. 8 2005 101 110
74. J. Zhao, N. Kobori, J. Aronowski, and P.K. Dash Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents Neurosci. Lett. 393 2006 108 112
75. A.I. Rojo, P. Rada, J. Egea, A.O. Rosa, M.G. Lopez, and A. Cuadrado Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death Mol. Cell. Neurosci. 39 2008 125 132
76. Z. Ping, W. Liu, Z. Kang, J. Cai, Q. Wang, N. Cheng, and et al. Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme Brain Res. 1343 2010 178 185
77. L. Soane, W. Li Dai, G. Fiskum, and L.L. Bambrick Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation J. Neurosci. Res. 88 2010 1355 1363
78. C.A. Danilov, K. Chandrasekaran, J. Racz, L. Soane, C. Zielke, and G. Fiskum Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation Glia 57 2009 645 656
79. M. Galuppo, S. Giacoppo, R. Iori, G.R. De Nicola, D. Milardi, P. Bramanti, and et al. 4-(α-l-Rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that defends cerebral tissue and prevents severe damage induced by focal ischemia/reperfusion J. Biol. Regul. Homeost. Agents 29 2015 343 356
80. W. Kirisattayakul, J. Wattanathorn, T. Tong-Un, S. Muchimapura, P. Wannanon, and J. Jittiwat Cerebroprotective effect of Moringa oleifera against focal ischemic stroke induced by middle cerebral artery occlusion Oxidative Med. Cell. Longev. 2013 2013 951415
81. A.I.R. Maas, N. Stocchetti, and R. Bullock Moderate and severe traumatic brain injury in adults Lancet Neurol. 7 2008 728 741
82. M. Gaetz The neurophysiology of brain injury Clin. Neurophysiol. 115 2004 4 18
83. P.K. Dash, J. Zhao, S.A. Orsi, M. Zhang, and A.N. Moore Sulforaphane improves cognitive function administered following traumatic brain injury Neurosci. Lett. 460 2009 103 107
84. J. Zhao, A.N. Moore, G.L. Clifton, and P.K. Dash Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury J. Neurosci. Res. 82 2005 499 506
85. J. Zhao, A.N. Moore, J.B. Redell, and P.K. Dash Enhancing expression of Nrf2-driven genes protects the blood-brain barrier after brain injury J. Neurosci. 27 2007 10240 10248
86. C. Profyris, S.S. Cheema, D. Zang, M.F. Azari, K. Boyle, and S. Petratos Degenerative and regenerative mechanisms governing spinal cord injury Neurobiol. Dis. 15 2004 415 436
87. L. Mao, H. Wang, X. Wang, H. Liao, and X. Zhao Transcription factor Nrf2 protects the spinal cord from inflammation produced by spinal cord injury J. Surg. Res. 170 2011 e105 e115
88. A.L. Benedict, A. Mountney, A. Hurtado, K.E. Bryan, R.L. Schnaar, A.T. Dinkova-Kostova, and et al. Neuroprotective effects of sulforaphane after contusive spinal cord injury J. Neurotrauma 29 2012 2576 2586
89. L. Mao, H.D. Wang, X.L. Wang, L. Qiao, and H.X. Yin Sulforaphane attenuates matrix metalloproteinase-9 expression following spinal cord injury in mice Ann. Clin. Lab. Sci. 40 2010 354 360
90. X. Wang, J.P. de Rivero Vaccari, H. Wang, P. Diaz, R. German, A.E. Marcillo, and et al. Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury J. Neurotrauma 29 2012 936 945
91. S)-glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model J. Neurol. Sci. 334 2013 88 96
92. S. Giacoppo, M. Galuppo, G.R. De Nicola, R. Iori, P. Bramanti, and E. Mazzon 4-(α-l-Rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury Bioorg. Med. Chem. 23 2015 80 88